NCT04642612 (CBF-TCD) is a clinical trial of TCD Measurement in Regional Anesthesia, sponsored by Stanford University.

Who is sponsoring NCT04642612?

NCT04642612 is sponsored by Stanford University.

What drugs are being tested in NCT04642612?

Interventions in NCT04642612: TCD Measurement.

What condition does NCT04642612 study?

NCT04642612 studies Regional Anesthesia, Horner Syndrome, Cerebral Blood Flow.

Is NCT04642612 still recruiting?

NCT04642612 is currently terminated. Last updated 16 September 2021.

Last reviewed 2021-09-16 · How we verify

NCT04642612: CBF-TCD

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Cerebral Blood Flow Evaluation With Trancranial Doppler After Interscalene Nerve Block

Terminated Last updated 16 September 2021

What this trial tests

trial testing TCD Measurement in Regional Anesthesia in 10 participants. Terminated before completion.

Timeline

4 March 2021

Primary endpoint
19 May 2021

30 July 2021

Quick facts

Lead sponsor	Stanford University
Status	Terminated
Study type	OBSERVATIONAL
Enrollment	10
Start date	4 March 2021
Primary completion	19 May 2021
Estimated completion	30 July 2021
Sites	1 location across United States

Drugs / interventions tested

TCD Measurement

Conditions studied

Regional Anesthesia — all drugs for Regional Anesthesia →
Horner Syndrome — all drugs for Horner Syndrome →
Cerebral Blood Flow — all drugs for Cerebral Blood Flow →

Sponsor

Stanford University

Who can join

Adults 18 to 85, any sex, with Regional Anesthesia or Horner Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to assess cerebral blood flow velocity (CBFV) following regional anesthesia for shoulder surgery. The results of this study will help to further understand the physiologic effect of the interscalene nerve block on cerebral blood flow.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Regional Anesthesia

Currently open trials in the same condition.

NCT07452120 — DIPB vs. SIFIB for Postoperative Analgesia After Hip Surgery · NA · recruiting
NCT07326644 — Effect of Gestational Weight Gain on Spinal Anesthesia in Elective Cesarean Delivery · recruiting
NCT07445854 — Sensory Analysis and Cutaneous Mapping of Different Regional Anesthesia Techniques · recruiting
NCT07221903 — The Lateral, Anterior, Medial (LAM) Femoral Cutaneous Block: A Case Series Harborview Medical Center, Seattle, WA · recruiting
NCT07176494 — Revision of Deep Brain Stimulator in Patients With Parkinson's Disease · NA · recruiting

Other Stanford University trials

Trials by the same sponsor.

NCT05945147 — Ketamine and Midazolam Infusions for CRPS: Feasibility Study · Phase 2 · withdrawn
NCT04225949 — Patients Understanding of PROM Graphs · NA · withdrawn
NCT06273098 — School-Based Bladder Health Intervention · NA · withdrawn
NCT04652635 — Management of Nailbed Injuries · NA · withdrawn
NCT05443503 — Stanford Spine Keeper - Managing Your Low Back Pain · NA · suspended

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04642612 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Stanford University
Last refreshed: 16 September 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04642612.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing